H7N9 analyses hint at genetic mutations, drug resistance | CIDRAP

In the latest H7N9 avian influenza developments, analysis of virus samples from China and Taiwan hint at mutations including resistance to the antiviral class of drugs known as neuraminidase inhibitors, and the World Health Organization (WHO) said today that the burgeoning number of cases this season now account for a third of all cases reported since the outbreak began in 2013.

Source: H7N9 analyses hint at genetic mutations, drug resistance | CIDRAP